We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Pharma group behind blockbuster drug wants to supersize its market impact
‘Treasure trove’ will be used to develop drugs and treatments for wide range of diseases and is culmination of 20 years of work
Non-profit offers $101mn for discoveries that will restore muscle, brain and immune functions
Cancer Research UK report says UK government must invest in staffing and funding for research
No evidence to support ‘popular ideas that certain groups are more at risk’, according to researchers
Innovative models can drive funding for research on neglected, less survivable diseases
Danish pharma group in talks with healthcare providers about innovative models to boost Wegovy take-up
Bill Anderson says group is generating a series of promising new drugs after R&D strategy change
Health body’s concern reflects heightened vigilance over signs of disease outbreaks since Covid pandemic
Vaccine recipient claims he suffered side effect of severe blood clot
German group says prospective blockbuster asundexian failed to demonstrate efficacy
A new crop of weight-loss drugs is disrupting markets as well as transforming waistlines
Study shows potential of technology to improve and speed up medical diagnoses
Regulator authorises treatment for sickle cell disease and beta thalassaemia
T-Therapeutics hopes to use genetically engineered rodents and machine learning to discover drugs
Anjana Ahuja selects her must-read titles
Covid may have abated, but emerging diseases and new drug categories are keeping the analytics firm busy
With real meat facing real problems, investors should cut back their exposure
Wegovy found to have ‘quite profound’ effect on reducing risk of heart attacks, says pharma group
Anglo-Swedish drugmaker’s oncology and rare disease medication sales offset waning demand for Covid jabs
US and UK regulators say diabetes medication showed ‘significant’ weight loss benefits
German group slashes guidance by €1bn and reduces spending as it expects fewer first vaccine doses and lower boosting
Findings show need to mitigate growing risks posed by animal-to-human pathogens such as coronaviruses
Findings could boost development of medical technology such as brain-machine interfaces
Biotech blames weaker US sales after lowering full-year forecast
International Edition
